Quantitative systems toxicology.

Area of Science:

• Pharmacology and Toxicology
• Computational Biology
• Drug Development

Background:

• Drug development faces high attrition rates due to inadequate efficacy and safety concerns.
• Traditional animal-based toxicity testing is time-consuming, costly, and may not accurately predict human risks.
• There is a critical need for innovative toxicity testing strategies to improve drug safety assessment.

Purpose of the Study:

• To explore the integration of computational modeling and in vitro methods for 21st-century toxicity testing.
• To discuss the application of quantitative systems toxicology (QST) models in predicting drug-induced toxicity.
• To highlight the potential of QST models in establishing individualized therapeutic windows for enhanced patient safety.

Main Methods:

• Reviewing the integration of quantitative structure-activity relationship (QSAR), network-based, and pharmacokinetic/pharmacodynamic (PK/PD) modeling approaches within QST frameworks.
• Examining the application of QST models for predicting cardiotoxicity and hepatotoxicity.
• Focusing on cell and organ-specific QST models.

Main Results:

• Quantitative systems toxicology (QST) models offer a promising approach to predict drug toxicity.
• Integration of QSAR, network-based, and PK/PD modeling enhances QST model capabilities.
• QST models have demonstrated potential in predicting specific toxicities like cardiotoxicity and hepatotoxicity.

Conclusions:

• QST models, integrating various computational approaches, are essential for modern toxicity testing.
• These models can significantly reduce reliance on animal testing and lower drug development costs.
• Cell and organ-specific QST models provide a foundation for personalized medicine by defining individual therapeutic windows and improving patient safety.